BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36376772)

  • 1. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.
    Choudhary NS; Saigal S; Thummala S; Saraf N; Rastogi A; Bhangui P; Srinivasan T; Yadav SK; Nundy S; Soin AS
    J Clin Exp Hepatol; 2020; 10(5):442-447. PubMed ID: 33029052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
    Kashyap R; Mantry P; Sharma R; Maloo MK; Safadjou S; Qi Y; Jain A; Maliakkal B; Ryan C; Orloff M
    J Gastrointest Surg; 2009 Aug; 13(8):1480-6. PubMed ID: 19430850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duct-to-duct Biliary Reconstruction in Living-donor Liver Transplantation for Primary Sclerosing Cholangitis: Report of a Case.
    Motomura T; Yoshizumi T; Wang H; Nagatsu A; Itoh S; Harada N; Harimoto N; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
    Transplant Proc; 2017 Jun; 49(5):1196-1198. PubMed ID: 28583556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic Living donor liver transplantation in irresectable intrahepatic cholangiocarcinoma in primary sclerosing cholangitis associated liver cirrhosis.
    Bednarsch J; Lang SA; Heise D; Strnad P; Neumann UP; Ulmer TF
    Z Gastroenterol; 2024 Jan; 62(1):50-55. PubMed ID: 38195108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry.
    Egawa H; Ueda Y; Ichida T; Teramukai S; Nakanuma Y; Onishi S; Tsubouchi H
    Am J Transplant; 2011 Mar; 11(3):518-27. PubMed ID: 21219581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of primary sclerosing cholangitis after living donor liver transplantation.
    Tamura S; Sugawara Y; Kaneko J; Matsui Y; Togashi J; Makuuchi M
    Liver Int; 2007 Feb; 27(1):86-94. PubMed ID: 17241386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
    Heinemann M; Liwinski T; Adam R; Berenguer M; Mirza D; Malek-Hosseini SA; Heneghan MA; Lodge P; Pratschke J; Boudjema K; Paul A; Zieniewicz K; Fronek J; Mehrabi A; Acarli K; Tokat Y; Coker A; Yilmaz S; Karam V; Duvoux C; Lohse AW; Schramm C;
    Am J Transplant; 2022 Feb; 22(2):626-633. PubMed ID: 34605157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.
    Henson JB; Patel YA; King LY; Zheng J; Chow SC; Muir AJ
    Liver Transpl; 2017 Jun; 23(6):769-780. PubMed ID: 28027592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
    Imai D; Yoshizumi T; Sakata K; Ikegami T; Itoh S; Harada N; Motomura T; Toshima T; Mano Y; Soejima Y; Maehara Y
    Transplantation; 2018 Sep; 102(9):e382-e391. PubMed ID: 29912047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis - a propensity score-matched intention-to-treat analysis.
    Åberg F; Sallinen V; Tuominen S; Adam R; Karam V; Mirza D; Heneghan MA; Line PD; Bennet W; Ericzon BG; Grat M; Lodge P; Rasmussen A; Schmelzle M; Thorburn D; Fondevila C; Helanterä I; Nordin A;
    J Hepatol; 2024 Jan; 80(1):99-108. PubMed ID: 37722533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
    J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic management of post-liver transplant billiary complications: A prospective study from tertiary centre in India.
    Ranjan P; Bansal RK; Mehta N; Lalwani S; Kumaran V; Sachdeva MK; Kumar M; Nundy S
    Indian J Gastroenterol; 2016 Jan; 35(1):48-54. PubMed ID: 26873087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of cholestatic liver disease after living donor liver transplantation.
    Tamura S; Sugawara Y; Kaneko J; Togashi J; Matsui Y; Yamashiki N; Kokudo N; Makuuchi M
    World J Gastroenterol; 2008 Sep; 14(33):5105-9. PubMed ID: 18777585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
    Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Hay JE; Charlton MR; Poterucha JJ; Rosen CB; Gores GJ; LaRusso NF; Krom RA
    Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.